China Trials 2025

위치: Shanghai, China

일정:

이벤트:

CHINATRIALS 2025 brings together global and regional leaders shaping the future of clinical research and biotech innovation, spanning early pipeline strategy, cross-border clinical development, and strategic partnerships. As a leading Asia-Pacific CRO and trusted global partner, Novotech will participate in two sessions on 13 November:

Novotech Participation (13 November):

  • Advancing xDC Therapies in China: Accelerating Clinical Development & Global Strategy (11:45–12:30)

Moderator: Helen Jiang, Chief Medical Officer, Shanghai Best-Link Bioscience

Panelists: Jian Zhang, Director of Medical Oncology, Fudan University Shanghai Cancer Center; Anwen Xiong, Associate Chief Physician & Associate Professor, Shanghai East Hospital; Shuhang Wang, Associate Chief Physician, Cancer Hospital Chinese Academy of Sciences; Jing Li, Vice President, Mabpharm; Yun Tian, Director of Medical Service and Strategy, Novotech.

  • Clinical Efficiency: Surviving a Changing Capital and Regulatory Environment (14:15–14:55)

Moderator: Irene Hong, Founding Partner, CEC Capital

Panelists: Anna French, Managing Partner, Qiming US; Andy Liu, General Manager, Novotech.

If you’d like to connect with our team in Shanghai, please schedule a meeting via the form on this page.

본 행사는 종료되었습니다.

노보텍에 관심을 가져주셔서 감사합니다. 행사는 종료되었지만, 노보텍의 전문가들은 임상 개발 전 단계에 걸쳐 스폰서를 지속적으로 지원하고 있습니다.

궁금한 점이 있거나 상담이 필요하신가요?

노보텍의 임상 개발 전문가와 상담해 보세요.

노보텍 참석자

Novotech China

Andy Liu

Novotech China
Managing Director
Novotech

Yun Tian

Novotech
Director of Medical Service and Strategy